REGULATED PRESS RELEASE published on 04/29/2025 at 19:13, 1 year 5 months ago Rapport Financier Annuel - 31/12/2024
BRIEF published on 04/25/2025 at 18:05, 1 year 6 months ago Euromedis Group: 2024 Annual Results Turnover Judicial Liquidation Geopolitical Tensions Euromedis Group 2024 Results
BRIEF published on 04/25/2025 at 18:05, 1 year 6 months ago Euromedis Groupe : Résultats annuels 2024 Chiffre D'affaires Résultats 2024 Liquidation Judiciaire Tensions Géopolitiques Euromedis Groupe
REGULATED PRESS RELEASE published on 04/25/2025 at 18:00, 1 year 6 months ago Euromedis - Communiqué résultat 2024 Le Conseil d’Administration annonce les résultats annuels 2024 avec une hausse de 6% du chiffre d'affaires malgré des défis. Des perspectives de croissance et d'économie pour 2025 Croissance Économie Résultats Annuels 2024 Perspectives 2025 Défis
BRIEF published on 12/10/2024 at 16:40, 1 year 10 months ago Laboratoires Euromedis : Ajustement du contrat de liquidité Liquidité AMF Regulation Titres Euromedis
BRIEF published on 12/10/2024 at 16:40, 1 year 10 months ago Euromedis Laboratories: Adjustment of the liquidity contract Liquidity Securities AMF Regulation Euromedis
REGULATED PRESS RELEASE published on 12/10/2024 at 16:35, 1 year 10 months ago LABORATOIRES EUROMEDIS - Ajustement du contrat de liquidité Modification du contrat de liquidité entre LABORATOIRES EUROMEDIS et la Société de Bourse Gilbert Dupont pour se conformer à la décision AMF n° 2018-01 du 2 juillet 2018. Retrait de 8 000 titres le 13 décembre 2024 Société De Bourse Gilbert Dupont Contrat De Liquidité AMF Laboratoires Euromedis Retrait
BRIEF published on 12/04/2024 at 18:05, 1 year 10 months ago Euromedis Laboratories: Successful OCA issuance Convertible Bonds Dilution Oversubscription Euromedis Preferential Right
BRIEF published on 12/04/2024 at 18:05, 1 year 10 months ago Laboratoires Euromedis : Réussite de l'émission d'OCA Obligations Convertibles Dilution Sursouscription Euromedis Droit Préférentiel
REGULATED PRESS RELEASE published on 12/04/2024 at 18:00, 1 year 10 months ago Laboratoires Euromedis - Succès de l'émission d'OCA avec maintien du DPS Succès de l’émission d’OCA avec maintien du DPS. Laboratoires Euromédis annonce l'émission de 624.975 OCA pour 2.999.880 euros Obligations Convertibles Émission D'actions Maintien Du DPS Laboratoires Euromedis Émission D'OCA
Published on 10/27/2026 at 23:40, 1 hour 20 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 1 hour 35 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 3 hours 30 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 3 hours 45 minutes ago Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 3 hours 50 minutes ago International Battery Metals Announces Leadership Transition
Published on 10/27/2026 at 22:40, 2 hours 19 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 2 hours 30 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 4 hours 25 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:17, 5 hours 42 minutes ago ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.
Published on 10/27/2026 at 18:00, 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 7 hours ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
